Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence [Yahoo! Finance]
Bionano Genomics, Inc. (BNGO)
Last bionano genomics, inc. earnings: 8/8 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
with Hangzhou Diagens Biotechnology Co., Ltd. (Diagens), the pioneering leader in artificial intelligence (AI) chromosome karyotype analysis technology. Their joint endeavor aims to commercialize the first ever cytogenetic workflow that integrates OGM plus AI chromosome karyotype analysis Diagens will become an original equipment manufacturing (OEM) partner of Bionano in China Diagens has received Class I registration and approval for Bionano's OGM reagents from China's National Medical Products Administration (NMPA) and plans to register the Saphyr™ instrument with NMPA for clinical use in reproductive health The cytogenetics workflow that Diagens expects to develop will combine AI analysis and OGM as a transformative approach to detecting pathogenic structural variants (SVs) associated with recurrent pregnancy loss and other significant genome variants that could impact a pregnancy or lead to developmental issues for the newborn SAN DIEGO, April 17, 2024 (GLOBE NEWSWIRE) --
Show less
Read more
Impact Snapshot
Event Time:
BNGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNGO alerts
High impacting Bionano Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
BNGO
News
- Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Bionano to Present at the RBC Capital Markets 2024 Global Healthcare ConferenceGlobeNewswire
- Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing [Yahoo! Finance]Yahoo! Finance
- Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore SequencingGlobeNewswire
- Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial IntelligenceGlobeNewswire
BNGO
Sec Filings
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- 4/8/24 - Form 8-K
- BNGO's page on the SEC website